mhurhangee/ep-ind-claims huggingface dataset:
Electrical connection assembly, comprising at least one electrical conductor (111, 112, 113) and at least one magnetic core (50A, 50B) for a current measurement sensor, in which the electrical conductor (111, 112, 113) extends through the magnetic core (50A, 50B) such that the magnetic core channels, in its at least one air gap, magnetic fields generated by a current circulating in the electrical conductor (111, 112, 113), the magnetic core (50A, 50B) comprising at least one ferromagnetic part (50A1, 50B1), the at least one ferromagnetic part (50A1, 50B1) comprising at least one concave portion, extending on a longitudinal plane (α) and at least partly delimiting an air gap; said air gap being able to receive a sensitive element of a measurement sensor, and the concave portion delimiting an internal space, able to receive an electrical conductor (111, 112, 113); the magnetic core (50A, 50B) having a longitudinal section of elliptical form, and the electrical connection assembly being characterized in that the inner edge of the magnetic core (50A, 50B) has a longitudinal section of elliptical form, said ellipse being the smallest ellipse circumscribed on the form of the electrical conductor (111, 112, 113) with a minimal distance between the form of the electrical conductor (111, 112, 113) and said inner edge, wherein said minimal distance is determined as a function of the half great axis (a) of said ellipse, of the half small axis (b) of said ellipse, of the angle (θ) between the great axis of the ellipse and a straight line passing through the centre of the ellipse, and of the greatest distance (ρ L, (θ)) of the longitudinal section of the electrical conductor (111, 112, 113) from the centre of the ellipse.
A method for wireless communications by a user equipment, UE, comprising: receiving, via a first component carrier, control information that triggers transmission of an aperiodic reference signal in a second component carrier, wherein the first component carrier has a lower subcarrier spacing, SCS, than the second component carrier, and wherein the control information is received in a physical downlink control channel, PDCCH, slot; identifying a quasi co-location assumption for reception of the aperiodic reference signal in the second component carrier based at least in part on a control resource set not being configured for the second component carrier; and receiving the aperiodic reference signal of the second component carrier based at least in part on the quasi co-location assumption, wherein the aperiodic reference signal comprises a channel state information reference signal, CSI-RS, and wherein the CSI-RS occurs only for later slots than a last slot overlapping the PDCCH slot. receiving, via a first component carrier, control information that triggers transmission of an aperiodic reference signal in a second component carrier, wherein the first component carrier has a lower subcarrier spacing, SCS, than the second component carrier, and wherein the control information is received in a physical downlink control channel, PDCCH, slot; identifying a quasi co-location assumption for reception of the aperiodic reference signal in the second component carrier based at least in part on a control resource set not being configured for the second component carrier; and receiving the aperiodic reference signal of the second component carrier based at least in part on the quasi co-location assumption, wherein the aperiodic reference signal comprises a channel state information reference signal, CSI-RS, and wherein the CSI-RS occurs only for later slots than a last slot overlapping the PDCCH slot.
A method for assembling an electronic module (10, 110) comprising the steps: mounting a base electronic component (16, 116) on a base substrate (12, 112); mounting a cover electronic component (18, 118) on a cover substrate (14, 114); depositing an electrically conductive filament directly onto the base electronic component or directly onto the cover electronic component; free-forming a self-supported interconnect pillar (20, 120, 220) with the deposited electrically conductive filament, the free-formed, self-supported interconnect pillar extending upright from the base electronic component or the cover electronic component; arranging the cover substrate over the opposing base substrate and aligning the base electronic component with the cover electronic component; electrically connecting the base electronic component to the cover electronic component with the free-formed, self-supported interconnect pillar; attaching a compressible electrical interposer at a free-end of the free-formed, self-supported interconnect pillar; and electrically interposing the compressible electrical interposer in the electrical path between the respective free-formed, self-supported interconnect pillar and the base electronic component or the cover electronic component. mounting a base electronic component (16, 116) on a base substrate (12, 112); mounting a cover electronic component (18, 118) on a cover substrate (14, 114); depositing an electrically conductive filament directly onto the base electronic component or directly onto the cover electronic component; free-forming a self-supported interconnect pillar (20, 120, 220) with the deposited electrically conductive filament, the free-formed, self-supported interconnect pillar extending upright from the base electronic component or the cover electronic component; arranging the cover substrate over the opposing base substrate and aligning the base electronic component with the cover electronic component; electrically connecting the base electronic component to the cover electronic component with the free-formed, self-supported interconnect pillar; attaching a compressible electrical interposer at a free-end of the free-formed, self-supported interconnect pillar; and electrically interposing the compressible electrical interposer in the electrical path between the respective free-formed, self-supported interconnect pillar and the base electronic component or the cover electronic component.
A data transmission method, wherein the method comprises: receiving, by a terminal device, first downlink control information DCI sent by a network device on a first downlink control channel, wherein a time segment corresponding to the first downlink control channel belongs to a first time segment; receiving, by the terminal device on a first downlink data channel indicated by the first DCI, a first transport block sent by the network device, wherein a time segment corresponding to the first downlink data channel belongs to the first time segment; receiving, by the terminal device, fourth DCI sent by the network device on a fourth downlink control channel, wherein a time segment corresponding to the fourth downlink control channel belongs to a second time segment, the second time segment is later than the first time segment, characterized in that the fourth DCI comprises first encoding information, and the first encoding information is used to indicate a first encoding mode of the first transport block; and performing, by the terminal device, decoding based on the first encoding information, to obtain the first transport block. receiving, by a terminal device, first downlink control information DCI sent by a network device on a first downlink control channel, wherein a time segment corresponding to the first downlink control channel belongs to a first time segment; receiving, by the terminal device on a first downlink data channel indicated by the first DCI, a first transport block sent by the network device, wherein a time segment corresponding to the first downlink data channel belongs to the first time segment; receiving, by the terminal device, fourth DCI sent by the network device on a fourth downlink control channel, wherein a time segment corresponding to the fourth downlink control channel belongs to a second time segment, the second time segment is later than the first time segment, characterized in that the fourth DCI comprises first encoding information, and the first encoding information is used to indicate a first encoding mode of the first transport block; and performing, by the terminal device, decoding based on the first encoding information, to obtain the first transport block.
A method for detecting malicious intermediate language files comprising: identifying, for analysis, a file whose size or checksum has changed, wherein the file is an intermediate language file; selecting a set of resources from the file being analyzed; calculating a perceptive hash of the set of resources; identifying a degree of similarly between the set of resources and a set of resources from known malicious files by comparing the perceptive hash with perceptive hashes of the set of resources from known malicious files; determining a harmfulness of the file being analyzed based on the degree of similarity; and removing or quarantining the file being analyzed when the harmfulness exceeds a predetermined threshold. identifying, for analysis, a file whose size or checksum has changed, wherein the file is an intermediate language file; selecting a set of resources from the file being analyzed; calculating a perceptive hash of the set of resources; identifying a degree of similarly between the set of resources and a set of resources from known malicious files by comparing the perceptive hash with perceptive hashes of the set of resources from known malicious files; determining a harmfulness of the file being analyzed based on the degree of similarity; and removing or quarantining the file being analyzed when the harmfulness exceeds a predetermined threshold.
A method of detecting or monitoring a risk of juvenile renal dysplasia or calcium oxalate stones in a dog, the method comprising detecting the presence of an allelic variant in the 5'UTR of canine Cox2 in a sample from the dog, wherein the presence of the variant is indicative of the risk of JRD or calcium oxalate stones in the dog; wherein the 5'UTR of canine Cox2 gene comprises nucleotides 49 - 175 of SEQ ID NO:5; wherein nucleotide 175 is at position -1; wherein the allelic variant in the 5'UTR of canine Cox2 gene comprises: (a) a deletion of 6 nucleotides starting at either position -73 or position -68 of SEQ ID NO:5 and a deletion of 11 nucleotides starting at position - 37 of SEQ ID NO:5; (b) an insertion of 12 nucleotides at position -78 of SEQ ID NO:5; or (c) an insertion of 24 nucleotides at position -78 of SEQ ID NO:5.
A pharmaceutical preparation for intravenous administration, comprising the following, namely: a) {8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl} acetic acid or a salt, a solvate or a solvate of a salt thereof, b) an excipient selected from the cyclodextrins, and c) water. a) {8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl} acetic acid or a salt, a solvate or a solvate of a salt thereof, b) an excipient selected from the cyclodextrins, and c) water.
A vehicle dashboard crossmember, said crossmember including a crossbar which extends lengthwise along a generatrix line intended to be oriented substantially along the width of the body of the vehicle, transversely to the direction of travel of said vehicle, as well as at least one connection flange (3, 4) designed to permit the fixing of said crossbar on the body of said vehicle, said crossmember being characterized in that said crossbar is formed, at least over a portion of its length, on the one hand by a first piece forming a load-bearing core which has a lateral wall rounded about said generatrix line, so as to present, in normal section to the generatrix line, a first branch and a second branch which are connected to one another by a common connection portion and which thus define a cavity, and on the other hand by a second piece, distinct from the first, which forms a reinforcing brace made of a fibrous composite material including fibres disposed in a matrix, and which connects the first branch to the second branch.
A high-density paper having a grammage measured according to ISO 536:2012 of 30-75 g/m 2 and a density measured according to ISO 534:2011 above 1000 kg/m 3 and wherein the high-density paper is impregnated on each side with 0.3-4.0 g/m 2, such as 0.5-3.0 g/m 2, of a polymer selected from the group consisting of polyvinyl alcohol (PVOH), ethylene vinyl alcohol (EVOH), carboxymethylated cellulose, nanocrystalline cellulose and carboxy methyl starch.
An electric motorcycle being a scooter-type electric motor cycle, the electric motor cycle comprising: an electric motor driving a rear wheel being a drive wheel; a battery supplying electric power to said electric motor; a controller unit performing drive control of said electric motor; a footrest section constructed between a front wheel and the rear wheel; and a controller housing compartment provided in a manner to be recessed downward in said footrest section, wherein said controller unit is disposed to be deflected in either side in the vehicle width direction in said footrest section; and a swing arm provided in a vehicle body frame in a manner to be vertically swingable, supporting the rear wheel in a manner to be freely rotatable, and supporting a power unit including said electric motor in one side in the vehicle width direction of the rear wheel, wherein said controller unit is disposed to be deflected in an opposite side in the vehicle width direction to the power unit including said electric motor, and wherein said controller unit has a configuration in which a connection section is provided in a side part of a center side in the vehicle width direction and a connection line connected to the connection section is led out toward one side in the vehicle width direction where said electric motor is mounted, characterized in that an opening is formed in a bottom of said controller housing compartment, and wherein said controller unit is provided, in its bottom, with a cooling fin protruding downward from the opening to face the outside, in a state of being housed in said controller housing compartment; and the vehicle body frame including a down tube extended downward from a head pipe and extendedly provided almost horizontally toward the rear from the middle; and a lower cover covering the upper side of the down tube, thereby constituting the footrest section. an electric motor driving a rear wheel being a drive wheel; a battery supplying electric power to said electric motor; a controller unit performing drive control of said electric motor; a footrest section constructed between a front wheel and the rear wheel; and a controller housing compartment provided in a manner to be recessed downward in said footrest section, wherein said controller unit is disposed to be deflected in either side in the vehicle width direction in said footrest section; and a swing arm provided in a vehicle body frame in a manner to be vertically swingable, supporting the rear wheel in a manner to be freely rotatable, and supporting a power unit including said electric motor in one side in the vehicle width direction of the rear wheel,
A structure comprising rigid elements connected together by interconnecting elements in such a way to form a statically determined structure or a statically over-determined structure, wherein said structure comprises at least one tension element comprising polymeric fibers comprising ultrahigh molecular weight polyethylene, said fibers having a stabilizing creep of at least 0.3 % and at most 10 % and a minimum creep rate lower than 1 x 10 -5 % per second, said stabilizing creep and minimum creep being measured utilizing the method described in the description at a tension of 900 MPa and a temperature of 30°C.
A method for assessing embryotoxicity of a chemical during myocardial differentiation comprising: a first step of measuring the expression level of a gene comprising any of the nucleotide sequences of SEQ ID NOs: 1 to 5 or an orthologous gene thereof in a sample from a mammalian cell which has come into contact with a test chemical; and a second step of comparing the measured value of the expression level of the gene in the sample obtained in the first step with a control value of the expression level of the gene and based on the difference assessing the level of the embryotoxicity of the test chemical in the sample, wherein the control value of the expression level of the gene is a measured value for the expression level of the gene in a sample from a mammalian cell which has not come into contact with the test chemical. a first step of measuring the expression level of a gene comprising any of the nucleotide sequences of SEQ ID NOs: 1 to 5 or an orthologous gene thereof in a sample from a mammalian cell which has come into contact with a test chemical; and a second step of comparing the measured value of the expression level of the gene in the sample obtained in the first step with a control value of the expression level of the gene and based on the difference assessing the level of the embryotoxicity of the test chemical in the sample, wherein the control value of the expression level of the gene is a measured value for the expression level of the gene in a sample from a mammalian cell which has not come into contact with the test chemical.
An isolated anti-Globo H antibody or an antigen-binding portion thereof, comprising the following: (i) a heavy chain complementarity determining region 1 (H-CDR1) consisting of the amino acid residues of GFSLGTFDLGIG (SEQ ID NO: 3); a heavy chain CDR2 (H-CDR2) consisting of the amino acid residues of HIWWDDDKYYNPA (SEQ ID NO:5); and a heavy chain CDR3 (H-CDR3) consisting of the amino acid residues of LSGNYLTSFYCDY (SEQ ID NO: 8); and a light chain CDR1 (L-CDR1) consisting of the amino acid residues of SARSSVSYMH (SEQ ID NO:12); a light chain CDR2 (L-CDR2) consisting of the amino acid residues of DTSKLAS (SEQ ID NO:16); and a light chain CDR3 (L-CDR3) consisting of the amino acid residues of QQWSSNPLT (SEQ ID NO: 18); or (ii) a heavy chain complementarity determining region 1 (H-CDR1) consisting of the amino acid residues of GFSLSTFDLGIG (SEQ ID NO: 4); a heavy chain CDR2 (H-CDR2) consisting of the amino acid residues of HIWWDDDKYYNPA (SEQ ID NO:5); and a heavy chain CDR3 (H-CDR3) consisting of the amino acid residues of LSGNYLTSFYCDY (SEQ ID NO: 8); and a light chain CDR1 (L-CDR1) consisting of the amino acid residues of SARSSVSYMH (SEQ ID NO:12); a light chain CDR2 (L-CDR2) consisting of the amino acid residues of DTSKLAS (SEQ ID NO:16); and a light chain CDR3 (L-CDR3) consisting of the amino acid residues of QQWSSNPLT (SEQ ID NO: 18); such that said antibody or antigen-binding portion thereof binds to Globo H. (i) a heavy chain complementarity determining region 1 (H-CDR1) consisting of the amino acid residues of GFSLGTFDLGIG (SEQ ID NO: 3); a heavy chain CDR2 (H-CDR2) consisting of the amino acid residues of HIWWDDDKYYNPA (SEQ ID NO:5); and a heavy chain CDR3 (H-CDR3) consisting of the amino acid residues of LSGNYLTSFYCDY (SEQ ID NO: 8); and a light chain CDR1 (L-CDR1) consisting of the amino acid residues of SARSSVSYMH (SEQ ID NO:12); a light chain CDR2 (L-CDR2) consisting of the amino acid residues of DTSKLAS (SEQ ID NO:16); and a light chain CDR3 (L-CDR3) consisting of the amino acid residues of QQWSSNPLT (SEQ ID NO: 18); or (ii) a heavy chain complementarity determining region 1 (H-CDR1) consisting of the amino acid residues of GFSLSTFDLGIG (SEQ ID NO: 4); a heavy chain CDR2 (H-CDR2) consisting of the amino acid residues of HIWWDDDKYYNPA (SEQ ID NO:5); and a heavy chain CDR3 (H-CDR3) consisting of the amino acid residues of LSGNYLTSFYCDY (SEQ ID NO: 8); and a light chain CDR1 (L-CDR1) consisting of the amino acid residues of SARSSVSYMH (SEQ ID NO:12); a light chain CDR2 (L-CDR2) consisting of the amino acid residues of DTSKLAS (SEQ ID NO:16); and a light chain CDR3 (L-CDR3) consisting of the amino acid residues of QQWSSNPLT (SEQ ID NO: 18); such that said antibody or antigen-binding portion thereof binds to Globo H.
A polypeptide being a partial peptide of a polypeptide represented by SEQ ID No: 1 or SEQ ID No: 2, having a length of 8 to 20 amino acids, and having HLA antigen-binding capacity.
A rapid-hardening additive comprising a heat-treated product which is obtained by heat-treating a mixture of a CaO raw material, a CaSO 4 raw material and at least one raw material selected from the group consisting of an Al 2 O 3 raw material, a Fe 2 O 3 raw material and a SiO 2 raw material, said heat-treated product containing from 10 to 70 parts by mass of free lime, from 10 to 50 parts by mass of a hydraulic compound and from 10 to 60 parts by mass of an anhydrous gypsum, per 100 parts by mass in total of the free lime, the hydraulic compound and the anhydrous gypsum, wherein the hydraulic compound is one or more of yeelimite represented by 3CaO·3Al 2 O 3 ·CaSO 4, a calcium silicate represented by 3CaO·SiO 2 or 2CaO·SiO 2, a calcium alumino ferrite represented by 4CaO·Al 2 O 3 ·Fe 2 O 3, 6CaO·2Al 2 O 3 ·Fe 2 O 3 or 6CaO·Al 2 O 3 ·Fe 2 O 3, or a calcium ferrite such as 2CaO·Fe 2 O 3, characterized in that the rapid-hardening additive contains from 0.1 to 10 parts by mass of glycerin in 100 parts by mass of the rapid-hardening additive.
A method for producing a parvovirus having an infectivity titer as high as 10 8 TCID 50 /mL or more in a culture supernatant by culturing host cells and a seed virus of the parvovirus in a culture substrate, comprising the steps of: (a) previously calculating: a doubling time of the host cells during the log growth phase in the culturing; and a cell density of the host cells confluently grown in the culturing; (b) inoculating the seed virus of the parvovirus into the culture substrate comprising the host cells having a cell density of 1/500 to 1/20 of the cell density of the host cells confluently grown previously calculated in the step (a) and a medium to give a multiplicity of infection of 0.0001 to 0.1; (c) culturing a culture comprising the host cells and the parvovirus of the step (b) for a period of 5 to 11 times the doubling time previously calculated in the step (a); and (d) recovering a culture supernatant comprising the parvovirus, obtained by the culturing step (c). (a) previously calculating: a doubling time of the host cells during the log growth phase in the culturing; and a cell density of the host cells confluently grown in the culturing; (b) inoculating the seed virus of the parvovirus into the culture substrate comprising the host cells having a cell density of 1/500 to 1/20 of the cell density of the host cells confluently grown previously calculated in the step (a) and a medium to give a multiplicity of infection of 0.0001 to 0.1; (c) culturing a culture comprising the host cells and the parvovirus of the step (b) for a period of 5 to 11 times the doubling time previously calculated in the step (a); and (d) recovering a culture supernatant comprising the parvovirus, obtained by the culturing step (c).